SERRATED POLYPOSIS SYNDROME

This adverse event was reported 3 times

SERRATED POLYPOSIS SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 COLESEVELAM HYDROCHLORIDE 1 0.0009
1 TEDUGLUTIDE 1 0.0001
2 CETIRIZINE HYDROCHLORIDE TABLETS 1 0.0000
3 PANCRELIPASE 1 0.0000
4 PANTOPRAZOLE SODIUM INJECTION 1 0.0000
5 UPADACITINIB 1 0.0000
6 HYDROCORTISONE 1 0.0000
7 LEVOTHYROXINE SODIUM ANHYDROUS 1 0.0000
8 USTEKINUMAB 1 0.0000
9 PANTOPRAZOLE SODIUM 1 0.0000
See all drugs enriched for association with SERRATED POLYPOSIS SYNDROME

SERRATED POLYPOSIS SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 GLP-2 Analog [EPC] 1 0.0001
1 Interleukin-12 Antagonist [EPC] 1 0.0000
2 Interleukin-23 Antagonist [EPC] 1 0.0000
3 Janus Kinase Inhibitor [EPC] 1 0.0000
4 Opioid Agonist [EPC] 1 0.0000
5 GLP-1 Receptor Agonist [EPC] 1 0.0000
6 Proton Pump Inhibitor [EPC] 1 0.0000
7 Benzodiazepine [EPC] 1 0.0000
8 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
9 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with SERRATED POLYPOSIS SYNDROME